New patterns of anti-HBe seroconversion during antiviral therapy for chronic hepatitis B.

被引：0
|
作者：
Zoulim, F
Pichoud, C
Stuyver, L
Berby, F
Trèpo, C
机构：
[1] INSERM U271, Lyon, France
[2] Innogenet, Ghent, Belgium
[3] INSERM U271, Lyon, France
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1927
引用
收藏
页码：642A / 642A
页数：1
相关论文
共 50 条
  • [41] DEFECTS IN THE PRECORE REGION OF THE HBV GENOME IN PATIENTS WITH CHRONIC HEPATITIS-B AFTER SUSTAINED SEROCONVERSION FROM HBEAG TO ANTI-HBE INDUCED SPONTANEOUSLY OR WITH INTERFERON THERAPY
    TAKEDA, K
    AKAHANE, Y
    SUZUKI, H
    OKAMOTO, H
    TSUDA, F
    MIYAKAWA, Y
    MAYUMI, M
    HEPATOLOGY, 1990, 12 (06) : 1284 - 1289
  • [42] Natural history of chronic hepatitis B in the Chinese: Prognostic significance of HBeAg/anti-HBe positivity
    Yuen, MF
    Wong, WM
    Cheng, CC
    Wu, CH
    Wu, PC
    Lai, CL
    HEPATOLOGY, 1997, 26 (04) : 751 - 751
  • [43] PROGNOSTIC VALUE OF HBE ANTIGEN AND ANTI-HBE ANTIBODY IN VIRAL HEPATITIS-B
    CHOSSEGROS, P
    TREPO, C
    BRETTE, R
    CHEVALLIER, P
    VITVISKI, L
    SEPETJAN, M
    NOUVELLE PRESSE MEDICALE, 1981, 10 (24): : 1993 - 1996
  • [44] SIGNIFICANCE OF HBEAG ANTI-HBE STATUS IN CHRONIC HEPATITIS AND HBCAG IN THE LIVER IN RELATION TO IMMUNOSUPPRESSIVE THERAPY
    FURUTA, S
    NAGATA, A
    KIYOSAWA, K
    AKAHANE, Y
    YAMAMURA, S
    SODEYAMA, T
    HEPATOLOGY, 1982, 2 (01) : 125 - 125
  • [45] Clinical characteristics and phase transition of chronic hepatitis B patients with HBeAg and anti-HBe coexistence
    Xue, Ruifei
    Wang, Jian
    Zhan, Jie
    Zhang, Zhiyi
    Jiang, Suling
    Xia, Juan
    Ding, Weimao
    Li, Jie
    Huang, Rui
    Wu, Chao
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1094 - S1094
  • [46] INFLUENCE OF VIRAL REPLICATION ON THE CLINICAL COURSE OF ANTI-HBE POSITIVE CHRONIC HEPATITIS-B
    SANCHEZTAPIAS, JM
    MAS, A
    COSTA, J
    BRUGUERA, M
    BALLESTA, AM
    RODES, J
    JOURNAL OF HEPATOLOGY, 1987, 5 : S198 - S198
  • [47] The natural history of anti-HBE positive (precore mutant) chronic hepatitis B patients.
    Lee, YM
    Wai, DCT
    Lim, LL
    Dong, P
    Perumal, V
    Chung, CK
    Lim, TP
    Ho, I
    Yeoh, KG
    Ho, KY
    Lim, SG
    HEPATOLOGY, 2000, 32 (04) : 575A - 575A
  • [48] Clearance of Serum HBsAg and Anti-HBs Seroconversion Following Antiviral Therapy for Chronic Hepatitis B
    Borgniet, Olivier
    Parvaz, Parviz
    Bouix, Cecile
    Chevallier, Philippe
    Trepo, Christian
    Andre, Patrice
    Zoulim, Fabien
    JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (08) : 1336 - 1342
  • [49] Clinical and prognostic significance of seroconversion from HBeAg to anti-HBe in chronic hepatitis B - Wartenberg-Study (1974-1994) .2.
    Ohlen, J
    Liegl, JM
    Selmair, H
    LEBER MAGEN DARM, 1995, 25 (06) : 259 - 262
  • [50] Analysis of factors affecting HBeAg early seroconversion to anti-HBe in acute exacerbation of HBeAg positive chronic hepatitis B with genotype c; a prospective study
    Kim, Hyoung Su
    Park, Ji Won
    Jang, Ji Sun
    Shin, Woon Geon
    Hoyim, Kyung
    Lee, Jin Heon
    Kim, Hak Yang
    Jang, Myoung Kuk
    GASTROENTEROLOGY, 2008, 134 (04) : A808 - A808
12345